COVID-19 Outcomes Among the Hispanic Population of 27 Large US Cities, 2020-2021

Isabel P De Ramos1, Mariana Lazo1, Alina Schnake-Mahl1

  • 1Isabel P. De Ramos, Mariana Lazo, Alina Schnake-Mahl, Ran Li, Ana V. Diez Roux, and Usama Bilal are with the Urban Health Collaborative, Dornsife School of Public Health, Drexel University, Philadelphia, PA. Ana P. Martinez-Donate is with the Department of Community Health and Prevention, Dornsife School of Public Health, Drexel University.

Insights

Hispanic populations experienced significantly higher COVID-19 incidence, hospitalization, and mortality rates compared to Whites. These racial/ethnic disparities persisted, particularly in areas with lower social vulnerability.

Area of Science:

  • Public Health
  • Epidemiology
  • Health Disparities Research

Background:

  • COVID-19 has disproportionately affected racial and ethnic minority groups in the United States.
  • Understanding the extent and nature of these disparities is crucial for targeted public health interventions.
  • Previous research indicates significant disparities, but comprehensive data across multiple urban jurisdictions is needed.

Purpose of the Study:

  • To analyze racial/ethnic disparities in COVID-19 outcomes (incidence, hospitalization, mortality, vaccination) between Hispanic and White populations.
  • To compare these disparities across 27 US cities within the Big Cities Health Coalition (BCHC).
  • To investigate the relationship between city-level social vulnerability and the magnitude of COVID-19 disparities.

Main Methods:

  • Utilized surveillance data from the BCHC COVID-19 dashboard (as of mid-June 2021).
  • Calculated crude incidence, age-adjusted hospitalization and mortality rates, and full vaccination coverage for Hispanic and White populations by city.
  • Estimated cumulative and yearly (2020, 2021) relative and absolute disparities, exploring associations with social vulnerability.

Main Results:

  • Hispanic populations exhibited 2.2-6.7 times higher COVID-19 incidence rates than Whites in most studied cities.
  • Age-adjusted hospitalization (1.5-8.6 times) and mortality (1.4-6.2 times) rates were higher among Hispanics in all cities.
  • Hispanic vaccination coverage was lower in all but one city; disparities narrowed for incidence and hospitalization in 2021 but persisted for mortality. Wider disparities were observed in cities with lower social vulnerability.

Conclusions:

  • Significant and persistent racial/ethnic disparities in COVID-19 outcomes exist between Hispanic and White populations across major US cities.
  • Lower social vulnerability in urban areas was paradoxically associated with wider COVID-19 outcome disparities.
  • Further in-depth research into these disparities is essential for developing effective strategies to protect marginalized communities.

Related Concept Videos

Pareto Chart00:52

Pareto Chart

A Pareto chart is a bar graph or a combination of both line and bar graphs. The bar lengths represent the individual values or the frequency, while the lines represent the cumulative total values. In this chart, the longest bars are arranged on the left and the shortest bars on the right, which makes it easier to read and interpret the data. It can also be called a Pareto diagram or Pareto analysis.
The Pareto chart is named after the Italian economist Vilfredo Pareto, who described the Pareto...
7.0K
Bias in Epidemiological Studies01:29

Bias in Epidemiological Studies

Biases can arise at various stages of research, from study design and data collection to analysis and interpretation. Recognizing and addressing these biases is essential to ensure the validity and reliability of epidemiological findings.Broadly speaking, biases in epidemiology fall into three main categories: selection bias, information bias, and confounding. A more detailed description of possible biases is:  
714
Statistical Methods for Analyzing Epidemiological Data01:25

Statistical Methods for Analyzing Epidemiological Data

Epidemiological data primarily involves information on specific populations' occurrence, distribution, and determinants of health and diseases. This data is crucial for understanding disease patterns and impacts, aiding public health decision-making and disease prevention strategies. The analysis of epidemiological data employs various statistical methods to interpret health-related data effectively. Here are some commonly used methods:
568
Prevalence and Incidence01:08

Prevalence and Incidence

In statistical epidemiology and health sciences, two essential metrics—prevalence and incidence—are fundamental for understanding disease dynamics within a population. These measures enable public health officials, epidemiologists, and researchers to assess the burden of diseases, allocate resources effectively, and design impactful public health policies and interventions.
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
843
Wilcoxon Signed-Ranks Test for Median of Single Population01:14

Wilcoxon Signed-Ranks Test for Median of Single Population

The Wilcoxon signed-rank test for the median of a single population is a nonparametric test used to evaluate whether the median of a population differs from a specified value. Unlike parametric tests, it does not require data to follow a normal distribution, making it suitable for non-normal or small samples. The test begins by calculating the difference (d) between each observation and the hypothesized median. The absolute values of these differences are ranked in ascending order, with ties...
240
Longitudinal Research02:20

Longitudinal Research

Sometimes we want to see how people change over time, as in studies of human development and lifespan. When we test the same group of individuals repeatedly over an extended period of time, we are conducting longitudinal research. Longitudinal research is a research design in which data-gathering is administered repeatedly over an extended period of time. For example, we may survey a group of individuals about their dietary habits at age 20, retest them a decade later at age 30, and then again...
12.5K